Stockreport

BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardio [Read more]